Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 372

1.

Neutrophil extracellular traps (NETs) exacerbate severity of infant sepsis.

Colón DF, Wanderley CW, Franchin M, Silva CM, Hiroki CH, Castanheira FVS, Donate PB, Lopes AH, Volpon LC, Kavaguti SK, Borges VF, Speck-Hernandez CA, Ramalho F, Carlotti AP, Carmona F, Alves-Filho JC, Liew FY, Cunha FQ.

Crit Care. 2019 Apr 8;23(1):113. doi: 10.1186/s13054-019-2407-8.

2.

CCR5-Positive Inflammatory Monocytes are Crucial for Control of Sepsis.

Castanheira FVES, de Lima KA, Cebinelli GCM, Sônego F, Kanashiro A, Colon DF, Borges V, Czaikoski PG, Mota JM, Cunha TM, Alves-Filho JC, Liew FY, Cunha FQ.

Shock. 2019 Nov;52(5):e100-e106. doi: 10.1097/SHK.0000000000001301.

PMID:
30724784
3.

Interleukin-33 contributes to disease severity in Dengue virus infection in mice.

Marques RE, Besnard AG, Maillet I, Fagundes CT, Souza DG, Ryffel B, Teixeira MM, Liew FY, Guabiraba R.

Immunology. 2018 Dec;155(4):477-490. doi: 10.1111/imm.12988. Epub 2018 Sep 10.

PMID:
30098206
4.

Targeting the IL33-NLRP3 axis improves therapy for experimental cerebral malaria.

Strangward P, Haley MJ, Albornoz MG, Barrington J, Shaw T, Dookie R, Zeef L, Baker SM, Winter E, Tzeng TC, Golenbock DT, Cruickshank SM, Allan SM, Craig A, Liew FY, Brough D, Couper KN.

Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7404-7409. doi: 10.1073/pnas.1801737115. Epub 2018 Jun 28.

5.

Smoking-induced aggravation of experimental arthritis is dependent of aryl hydrocarbon receptor activation in Th17 cells.

Talbot J, Peres RS, Pinto LG, Oliveira RDR, Lima KA, Donate PB, Silva JR, Ryffel B, Cunha TM, Alves-Filho JC, Liew FY, Louzada-Junior P, de Queiroz Cunha F.

Arthritis Res Ther. 2018 Jun 8;20(1):119. doi: 10.1186/s13075-018-1609-9.

6.

Interleukin-33 Receptor (ST2) Deficiency Improves the Outcome of Staphylococcus aureus-Induced Septic Arthritis.

Staurengo-Ferrari L, Trevelin SC, Fattori V, Nascimento DC, de Lima KA, Pelayo JS, Figueiredo F, Casagrande R, Fukada SY, Teixeira MM, Cunha TM, Liew FY, Oliveira RD, Louzada-Junior P, Cunha FQ, Alves-Filho JC, Verri WA.

Front Immunol. 2018 May 16;9:962. doi: 10.3389/fimmu.2018.00962. eCollection 2018.

7.

The Atypical Chemokine Receptor ACKR2 is Protective Against Sepsis.

Castanheira FVES, Borges V, Sônego F, Kanashiro A, Donate PB, Melo PH, Pallas K, Russo RC, Amaral FA, Teixeira MM, Ramalho FS, Cunha TM, Liew FY, Alves-Filho JC, Graham GJ, Cunha FQ.

Shock. 2018 Jun;49(6):682-689. doi: 10.1097/SHK.0000000000000969.

PMID:
29589840
8.

TGF-β signalling defect is linked to low CD39 expression on regulatory T cells and methotrexate resistance in rheumatoid arthritis.

Peres RS, Donate PB, Talbot J, Cecilio NT, Lobo PR, Machado CC, Lima KWA, Oliveira RD, Carregaro V, Nakaya HI, Cunha TM, Alves-Filho JC, Liew FY, Louzada-Junior P, Cunha FQ.

J Autoimmun. 2018 Jun;90:49-58. doi: 10.1016/j.jaut.2018.01.004. Epub 2018 Feb 14.

PMID:
29426578
9.

M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza.

Cole SL, Dunning J, Kok WL, Benam KH, Benlahrech A, Repapi E, Martinez FO, Drumright L, Powell TJ, Bennett M, Elderfield R, Thomas C; MOSAIC investigators, Dong T, McCauley J, Liew FY, Taylor S, Zambon M, Barclay W, Cerundolo V, Openshaw PJ, McMichael AJ, Ho LP.

JCI Insight. 2017 Apr 6;2(7):e91868. doi: 10.1172/jci.insight.91868.

10.

IL-33 contributes to sepsis-induced long-term immunosuppression by expanding the regulatory T cell population.

Nascimento DC, Melo PH, Piñeros AR, Ferreira RG, Colón DF, Donate PB, Castanheira FV, Gozzi A, Czaikoski PG, Niedbala W, Borges MC, Zamboni DS, Liew FY, Cunha FQ, Alves-Filho JC.

Nat Commun. 2017 Apr 4;8:14919. doi: 10.1038/ncomms14919.

11.

Interleukin-33 in health and disease.

Liew FY, Girard JP, Turnquist HR.

Nat Rev Immunol. 2016 Nov;16(11):676-689. doi: 10.1038/nri.2016.95. Epub 2016 Sep 19. Review.

PMID:
27640624
12.

IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline.

Fu AK, Hung KW, Yuen MY, Zhou X, Mak DS, Chan IC, Cheung TH, Zhang B, Fu WY, Liew FY, Ip NY.

Proc Natl Acad Sci U S A. 2016 May 10;113(19):E2705-13. doi: 10.1073/pnas.1604032113. Epub 2016 Apr 18.

13.

Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain.

Zarpelon AC, Rodrigues FC, Lopes AH, Souza GR, Carvalho TT, Pinto LG, Xu D, Ferreira SH, Alves-Filho JC, McInnes IB, Ryffel B, Quesniaux VF, Reverchon F, Mortaud S, Menuet A, Liew FY, Cunha FQ, Cunha TM, Verri WA Jr.

FASEB J. 2016 Jan;30(1):54-65. doi: 10.1096/fj.14-267146. Epub 2015 Aug 26.

PMID:
26310268
14.

MicroRNA29a regulates IL-33-mediated tissue remodelling in tendon disease.

Millar NL, Gilchrist DS, Akbar M, Reilly JH, Kerr SC, Campbell AL, Murrell GAC, Liew FY, Kurowska-Stolarska M, McInnes IB.

Nat Commun. 2015 Apr 10;6:6774. doi: 10.1038/ncomms7774.

15.

IL-33 Exacerbates Periodontal Disease through Induction of RANKL.

Malcolm J, Awang RA, Oliver-Bell J, Butcher JP, Campbell L, Adrados Planell A, Lappin DF, Fukada SY, Nile CJ, Liew FY, Culshaw S.

J Dent Res. 2015 Jul;94(7):968-75. doi: 10.1177/0022034515577815. Epub 2015 Mar 25.

PMID:
25808546
16.

Cigarette smoke resets the Alarmin IL-33 in COPD.

Liew FY.

Immunity. 2015 Mar 17;42(3):401-3. doi: 10.1016/j.immuni.2015.02.014.

17.

Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis.

Peres RS, Liew FY, Talbot J, Carregaro V, Oliveira RD, Almeida SL, França RF, Donate PB, Pinto LG, Ferreira FI, Costa DL, Demarque DP, Gouvea DR, Lopes NP, Queiroz RH, Silva JS, Figueiredo F, Alves-Filho JC, Cunha TM, Ferreira SH, Louzada-Junior P, Cunha FQ.

Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):2509-14. doi: 10.1073/pnas.1424792112. Epub 2015 Feb 9.

18.

IL-33-mediated protection against experimental cerebral malaria is linked to induction of type 2 innate lymphoid cells, M2 macrophages and regulatory T cells.

Besnard AG, Guabiraba R, Niedbala W, Palomo J, Reverchon F, Shaw TN, Couper KN, Ryffel B, Liew FY.

PLoS Pathog. 2015 Feb 6;11(2):e1004607. doi: 10.1371/journal.ppat.1004607. eCollection 2015 Feb.

19.

IL-33 attenuates the development of experimental autoimmune uveitis.

Barbour M, Allan D, Xu H, Pei C, Chen M, Niedbala W, Fukada SY, Besnard AG, Alves-Filho JC, Tong X, Forrester JV, Liew FY, Jiang HR.

Eur J Immunol. 2014 Nov;44(11):3320-9. doi: 10.1002/eji.201444671. Epub 2014 Oct 18.

20.

Nitric oxide enhances Th9 cell differentiation and airway inflammation.

Niedbala W, Besnard AG, Nascimento DC, Donate PB, Sonego F, Yip E, Guabiraba R, Chang HD, Fukada SY, Salmond RJ, Schmitt E, Bopp T, Ryffel B, Liew FY.

Nat Commun. 2014 Aug 7;5:4575. doi: 10.1038/ncomms5575.

21.

IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice.

Li D, Guabiraba R, Besnard AG, Komai-Koma M, Jabir MS, Zhang L, Graham GJ, Kurowska-Stolarska M, Liew FY, McSharry C, Xu D.

J Allergy Clin Immunol. 2014 Dec;134(6):1422-1432.e11. doi: 10.1016/j.jaci.2014.05.011. Epub 2014 Jun 27.

22.

IL-10-producing regulatory B cells induced by IL-33 (Breg(IL-33)) effectively attenuate mucosal inflammatory responses in the gut.

Sattler S, Ling GS, Xu D, Hussaarts L, Romaine A, Zhao H, Fossati-Jimack L, Malik T, Cook HT, Botto M, Lau YL, Smits HH, Liew FY, Huang FP.

J Autoimmun. 2014 May;50:107-22. doi: 10.1016/j.jaut.2014.01.032. Epub 2014 Feb 1.

23.

Type 2 innate lymphoid cells drive CD4+ Th2 cell responses.

Mirchandani AS, Besnard AG, Yip E, Scott C, Bain CC, Cerovic V, Salmond RJ, Liew FY.

J Immunol. 2014 Mar 1;192(5):2442-8. doi: 10.4049/jimmunol.1300974. Epub 2014 Jan 27.

24.

IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice.

Guabiraba R, Besnard AG, Menezes GB, Secher T, Jabir MS, Amaral SS, Braun H, Lima-Junior RC, Ribeiro RA, Cunha FQ, Teixeira MM, Beyaert R, Graham GJ, Liew FY.

Mucosal Immunol. 2014 Sep;7(5):1079-93. doi: 10.1038/mi.2013.124. Epub 2014 Jan 15.

25.

An interleukin-33/ST2 signaling deficiency reduces overt pain-like behaviors in mice.

Magro DA, Hohmann MS, Mizokami SS, Cunha TM, Alves-Filho JC, Casagrande R, Ferreira SH, Liew FY, Cunha FQ, Verri WA Jr.

Braz J Med Biol Res. 2013 Jul;46(7):601-6. doi: 10.1590/1414-431X20132894. Epub 2013 Jul 16.

26.

The IL-33/ST2 pathway controls coxsackievirus B5-induced experimental pancreatitis.

Sesti-Costa R, Silva GK, Proença-Módena JL, Carlos D, Silva ML, Alves-Filho JC, Arruda E, Liew FY, Silva JS.

J Immunol. 2013 Jul 1;191(1):283-92. doi: 10.4049/jimmunol.1202806. Epub 2013 Jun 3.

27.

Nitric oxide-induced regulatory T cells inhibit Th17 but not Th1 cell differentiation and function.

Niedbala W, Besnard AG, Jiang HR, Alves-Filho JC, Fukada SY, Nascimento D, Mitani A, Pushparaj P, Alqahtani MH, Liew FY.

J Immunol. 2013 Jul 1;191(1):164-70. doi: 10.4049/jimmunol.1202580. Epub 2013 May 29.

28.

Novel allergic asthma model demonstrates ST2-dependent dendritic cell targeting by cypress pollen.

Gabriele L, Schiavoni G, Mattei F, Sanchez M, Sestili P, Butteroni C, Businaro R, Mirchandani A, Niedbala W, Liew FY, Afferni C.

J Allergy Clin Immunol. 2013 Sep;132(3):686-695.e7. doi: 10.1016/j.jaci.2013.02.037. Epub 2013 Apr 19.

PMID:
23608732
29.

IL-33/ST2 signalling contributes to carrageenin-induced innate inflammation and inflammatory pain: role of cytokines, endothelin-1 and prostaglandin E2.

Zarpelon AC, Cunha TM, Alves-Filho JC, Pinto LG, Ferreira SH, McInnes IB, Xu D, Liew FY, Cunha FQ, Verri WA Jr.

Br J Pharmacol. 2013 May;169(1):90-101. doi: 10.1111/bph.12110.

30.

Aeromonas aquariorum clinical isolates: antimicrobial profiles, plasmids and genetic determinants.

Puah SM, Puthucheary SD, Liew FY, Chua KH.

Int J Antimicrob Agents. 2013 Mar;41(3):281-4. doi: 10.1016/j.ijantimicag.2012.11.012. Epub 2013 Jan 9.

PMID:
23312608
31.

There is no banquet that never ends.

Liew FY.

Eur J Immunol. 2012 Dec;42(12):i. doi: 10.1002/eji.201270094. No abstract available.

32.

Retraction: Recombinant migration inhibitory factor induces nitric oxide synthase in murine macrophages.

Moncada S, Liew FY.

J Immunol. 2012 Sep 15;189(6):3260. doi: 10.4049/jimmunol.1290047. No abstract available.

33.

Retraction. The cytokine interleukin-33 mediates anaphylactic shock.

Pushparaj PN, Tay HK, H'ng SC, Pitman N, Xu D, McKenzie A, Liew FY.

Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13877. doi: 10.1073/pnas.1210844109. Epub 2012 Aug 13. No abstract available. Erratum in: Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15527.

34.

IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mammalian target of rapamycin.

Salmond RJ, Mirchandani AS, Besnard AG, Bain CC, Thomson NC, Liew FY.

J Allergy Clin Immunol. 2012 Nov;130(5):1159-1166.e6. doi: 10.1016/j.jaci.2012.05.018. Epub 2012 Jun 26.

35.

Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice.

Komai-Koma M, Brombacher F, Pushparaj PN, Arendse B, McSharry C, Alexander J, Chaudhuri R, Thomson NC, McKenzie AN, McInnes I, Liew FY, Xu D.

Allergy. 2012 Sep;67(9):1118-26. doi: 10.1111/j.1398-9995.2012.02859.x. Epub 2012 Jun 15.

36.

Interleukin-33 and the function of innate lymphoid cells.

Mirchandani AS, Salmond RJ, Liew FY.

Trends Immunol. 2012 Aug;33(8):389-96. doi: 10.1016/j.it.2012.04.005. Epub 2012 May 19. Review.

PMID:
22609147
37.

IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages.

Jiang HR, Milovanović M, Allan D, Niedbala W, Besnard AG, Fukada SY, Alves-Filho JC, Togbe D, Goodyear CS, Linington C, Xu D, Lukic ML, Liew FY.

Eur J Immunol. 2012 Jul;42(7):1804-14. doi: 10.1002/eji.201141947. Epub 2012 Jun 12.

38.

IL-33: a Janus cytokine.

Liew FY.

Ann Rheum Dis. 2012 Apr;71 Suppl 2:i101-4. doi: 10.1136/annrheumdis-2011-200589. Review.

PMID:
22460136
39.
40.

IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.

Turnquist HR, Zhao Z, Rosborough BR, Liu Q, Castellaneta A, Isse K, Wang Z, Lang M, Stolz DB, Zheng XX, Demetris AJ, Liew FY, Wood KJ, Thomson AW.

J Immunol. 2011 Nov 1;187(9):4598-610. doi: 10.4049/jimmunol.1100519. Epub 2011 Sep 26.

41.

MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis.

Kurowska-Stolarska M, Alivernini S, Ballantine LE, Asquith DL, Millar NL, Gilchrist DS, Reilly J, Ierna M, Fraser AR, Stolarski B, McSharry C, Hueber AJ, Baxter D, Hunter J, Gay S, Liew FY, McInnes IB.

Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11193-8. doi: 10.1073/pnas.1019536108. Epub 2011 Jun 20.

42.

IL-33 induces skin inflammation with mast cell and neutrophil activation.

Hueber AJ, Alves-Filho JC, Asquith DL, Michels C, Millar NL, Reilly JH, Graham GJ, Liew FY, Miller AM, McInnes IB.

Eur J Immunol. 2011 Aug;41(8):2229-37. doi: 10.1002/eji.201041360. Epub 2011 Jun 24.

43.

Regulation of type 17 helper T-cell function by nitric oxide during inflammation.

Niedbala W, Alves-Filho JC, Fukada SY, Vieira SM, Mitani A, Sonego F, Mirchandani A, Nascimento DC, Cunha FQ, Liew FY.

Proc Natl Acad Sci U S A. 2011 May 31;108(22):9220-5. doi: 10.1073/pnas.1100667108. Epub 2011 May 16.

44.

IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNF-alpha-mediated bone loss.

Zaiss MM, Kurowska-Stolarska M, Böhm C, Gary R, Scholtysek C, Stolarski B, Reilly J, Kerr S, Millar NL, Kamradt T, McInnes IB, Fallon PG, David JP, Liew FY, Schett G.

J Immunol. 2011 Jun 1;186(11):6097-105. doi: 10.4049/jimmunol.1003487. Epub 2011 Apr 22.

45.

The IL-33/ST2 pathway--A new therapeutic target in cardiovascular disease.

Miller AM, Liew FY.

Pharmacol Ther. 2011 Aug;131(2):179-86. doi: 10.1016/j.pharmthera.2011.02.005. Epub 2011 Feb 26. Review.

PMID:
21356240
46.

What can the periodontal community learn from the pathophysiology of rheumatoid arthritis?

Culshaw S, McInnes IB, Liew FY.

J Clin Periodontol. 2011 Mar;38 Suppl 11:106-13. doi: 10.1111/j.1600-051X.2010.01669.x. Review.

PMID:
21323707
47.

IL-33 activates B1 cells and exacerbates contact sensitivity.

Komai-Koma M, Gilchrist DS, McKenzie AN, Goodyear CS, Xu D, Liew FY.

J Immunol. 2011 Feb 15;186(4):2584-91. doi: 10.4049/jimmunol.1002103. Epub 2011 Jan 14.

48.

Collagen-induced arthritis is not impaired in mast cell-deficient mice.

Pitman N, Asquith DL, Murphy G, Liew FY, McInnes IB.

Ann Rheum Dis. 2011 Jun;70(6):1170-1. doi: 10.1136/ard.2010.134528. Epub 2010 Dec 3. No abstract available.

PMID:
21131642
49.

IL-33 exacerbates eosinophil-mediated airway inflammation.

Stolarski B, Kurowska-Stolarska M, Kewin P, Xu D, Liew FY.

J Immunol. 2010 Sep 15;185(6):3472-80. doi: 10.4049/jimmunol.1000730. Epub 2010 Aug 6.

50.

Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice.

Miller AM, Asquith DL, Hueber AJ, Anderson LA, Holmes WM, McKenzie AN, Xu D, Sattar N, McInnes IB, Liew FY.

Circ Res. 2010 Sep 3;107(5):650-8. doi: 10.1161/CIRCRESAHA.110.218867. Epub 2010 Jul 15.

Supplemental Content

Support Center